Spotlight: 1 Gene Editing Stock Set To Skyrocket
Cathie Wood has been investing heavily in Verve Therapeutics (VERV), a company developing therapies for cardiovascular diseases. So what’s all the fuss about? We took a deeper dive to find out.
The Spotlight
51% Of Buffett’s Portfolio Is In 1 Stock
Warren Buffett is one of the most successful investors of all time. He has made billions of dollars by following a simple investment philosophy: invest in companies with strong competitive advantages that are trading at fair prices.
One of Buffett’s favorite companies is Apple now represents an astonishing 51% of his entire stock portfolio.
» Read more about: 51% Of Buffett’s Portfolio Is In 1 Stock »
Market Commentary: Buffett Loaded Up On 1 Stock Every Quarter For 5 Years
Warren Buffett may be old but he’s fearless when it comes to making massive bets. One such outsized investment is Apple, which now represents close to 50% of his equity portfolio (see below).
Imagine having so much conviction in a single company that you allocate half your money to it. Now further consider having a portfolio the size of Buffett’s and making that same bet.
» Read more about: Market Commentary: Buffett Loaded Up On 1 Stock Every Quarter For 5 Years »
Spotlight: 1 Heart Transplant Stock Up Over 500%
TransMedics (NASDAQ:TMDX) has emerged as a prominent player in the medical field, witnessing a remarkable surge from $14 to $90 in a little over 18 months.
The company’s core expertise lies in organ care systems, which preserve transplant organs post-donor retrieval.
Spotlight: 1 Stunning Stock To Hold For 10 Years
Have you ever been to a public restroom and wondered how the company that runs the soap dispensary fares? If not, let me lift the veil. If so, you may already be familiar with the name Cintas.
Cintas Corporation (NASDAQ:CTAS) is a leading provider of restroom supplies,
» Read more about: Spotlight: 1 Stunning Stock To Hold For 10 Years »
Spotlight: Dine On Steak After This Brazilian Breakout
Rates are going up everywhere, at least that’s what the financial press would have you believe. On July 26, Federal Reserve Chairman Jerome Powell oversaw a rate hike that placed interest rates at 22 year highs, pegging them at 5.25-5.50%.
The market had largely priced in the rate hike and so the S&P 500 fell just 0.17% on the day.
» Read more about: Spotlight: Dine On Steak After This Brazilian Breakout »
Spotlight: Are You About To Lose A Fortune?
The turtle and hare game is so apt in investing. Why chase the fast bucks when slow and steady wins the race? Where investing gets tough is when the tortoise approach turns into a game of switcharoo, where you the investor gets the rug pulled on you. What am I talking about?
» Read more about: Spotlight: Are You About To Lose A Fortune? »
Spotlight: How To Spot a Breakout
Perhaps there is no better technical pattern to master if you want to consistently and predictably generate superior returns than the breakout.
It’s a generic term that applies to a wide range of chart patterns, including basic support and resistance, as well as flag patterns, cup-and-handles, and many others. So,
Spotlight: 99% Lower, Time To Buy This Weed Stock?
Cannabis company SNDL, formerly known as Sundial Growers, has fallen more than 99 percent from its record closing high of $130. Now trading at less than $1.50 per share, the stock has been one of the biggest losers of the last few years. Its massive contraction in value, however, has left many investors wondering whether it has become oversold.
» Read more about: Spotlight: 99% Lower, Time To Buy This Weed Stock? »
Spotlight: Will This Weed Stock Get Your Portfolio High?
Canopy Growth was at the forefront of the cannabis industry just a few years ago. But the Canadian cannabis producer has faced significant struggles that have reduced its valuation from billions to millions, as revenues have declined and losses have piled up.
In 2018, Canopy stock pushed past $50 per share, but investors have gradually given up on the stock since then.
» Read more about: Spotlight: Will This Weed Stock Get Your Portfolio High? »